/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.69%
Natural Gas
+1.30%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.09%
VIX
N/A
Economic Calendar
EUR/USD
-0.69%
Natural Gas
+1.30%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.09%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Crude Inventories Rise By 1.6 Million Barrels, Exceeding Analyst Estimates
about 18 hours ago
US Q3 GDP Growth Surges, Surpassing Expectations
about 18 hours ago
CB Consumer Confidence Declined In November
2 days ago
Case-Shiller, FHFA: US Home Prices Soar to Record High, Up 5.5% Annually
2 days ago
OPEC+’s Crucial Production Cut Verdict Will Be A Turning Point for Oil Prices
2 days ago
Dallas Fed Manufacturing Index Falls As Factory Activity Contracts
3 days ago
Crypto Market: Another Pullback Within The Framework Of Growth
about 2 hours ago
Ethereum (ETH) Price Outperformed Bitcoin in November –Will it Happen Again?
about 1 hour ago
Silver Prices Forecast: Steady as Market Eyes Key US Inflation Data
about 3 hours ago
Gold Prices Forecast: Testing Seven-Month High Ahead of Key US Inflation Report
about 3 hours ago
Oil Prices Forecast: Traders Bracing for OPEC+ Crucial Production Decision
about 3 hours ago
GBP to USD Forecast: A Hawkish Bank of England and US Inflation in the Spotlight
about 3 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
BDSwiss Academy
ad
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
FULC
profile
Fulcrum Therapeutics Inc
Follow
FULC
(
Nasdaq - US
)
Closed
4.79
+0.23 (+5.04%)
in
:
usd
•
As of: Nov 29, 2023 15:59
UTC -5
Open
4.69
High
4.88
Low
4.69
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Fulcrum Therapeutics Inc
CEO
Robert J. Gould
Headquarters
26 landsdowne street
cambridge, ma 02139, united states
Auditor
Ernst & Young LLP
Employees
89
Share Holders
17
Website
www.fulcrumtx.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.
Fulcrum Therapeutics Inc
Statistics
Valuation Measures
Market Capitalization
2
296.12M
Enterprise Value
266.04M
Enterprise Value/EBITDA
(ttm)
-2.45
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
1.17
Price to Sales
(ttm)
114.25
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
100.00%
Operating Margin
(ttm)
-3769.15%
Profit Margin
(ttm)
-4520.47%
Return on Equity
(ttm)
-38.48%
Return on Invested Capital
(ttm)
-39.54%
Return on Assets
(ttm)
-35.04%
Income Statement
Revenue
(ttm)
2.62M
Revenue Per Share
(ttm)
0.04
Gross Profit
(ttm)
2.62M
EBITDA
(ttm)
3
-108.39M
Net Income Avi to Common
(ttm)
-98.71M
Diluted EPS
(ttm)
-1.68
Share Statistics
Beta (5Y Monthly)
2.15
52-Week Change
-30.07%
S&P500 52-Week Change
11.53%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
61.82M
Dividend Yield
0.00%
Float
4
60.28M
%
Held by Insiders
2.50%
%
Held by Institutions
89.83%
Balance Sheet
Total Cash
(mrq)
257.09M
Total Cash Per Share
(mrq)
4.16
Total Debt
(mrq)
0.00
Total Debt/Equity
(mrq)
0.00%
Current Ratio
(mrq)
18.65%
Quick Ratio
(mrq)
18.65%
Book Value Per Share
(mrq)
4.13
Cash Flow
Operating Cash Flow Per Share
(ytd)
-1.10
Free Cash Flow
(ytd)
-68.24M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker